Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
Design student helps develop ventilation hood that has the potential to save lives of COVID-19 patients
27 April 2021New mouse model provides first platform to study late-onset Alzheimer’s disease
27 April 2021Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults hospitalized with complicated S. aureus infection at approximately 20 trial sites around the United States. The trial is being sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
